The Chronic Treatment With 5-HT2A Receptor Agonists Affects the Behavior and the BDNF System in Mice
- PMID:33095437
- DOI: 10.1007/s11064-020-03153-5
The Chronic Treatment With 5-HT2A Receptor Agonists Affects the Behavior and the BDNF System in Mice
Abstract
Serotonin 5-HT2A receptors and the brain-derived neurotrophic factor (BDNF) are involved in the pathophysiology and treatment of many psychiatric diseases. However, the interaction between 5-HT2A and BDNF is still poorly understood. In the present paper, the effects of chronic treatment with mixed 5-HT2A/2C receptor agonist DOI, highly selective 5-HT2A agonists TCB-2 and 25CN-NBOH on behavior and the BDNF system have been investigated. Chronic treatment of males of C57Bl/6 mice with DOI, TCB-2 and 25CN-NBOH (1 mg/kg, i.p., 14 days) resulted in desensitization of 5-HT2A receptors. Treatment with 25CN-NBOH significantly increased startle amplitude. At the same time all used drugs failed to affect anxiety, exploratory and stereotyped behavior as well as spatial memory and learning. TCB-2 and 25CN-NBOH increased the BDNF mRNA level. All 5-HT2A agonists increased the proBDNF level but failed to alter the mature BDNF protein level. TrkB and p75NTR mRNA levels were affected by all utilized agonists. All drugs decreased the total level as well as membrane TrkB protein one indicating downregulation of TrkB receptors. All agonists decreased the membrane p75NTR protein level. Thus, we have shown for the first time that the chronic activation of the 5-HT2A receptor with agonists has affected the BDNF system almost on all levels-transcription, proBDNF production, TrkB and p75NTR receptors' level. The obtained data suggested possible suppression in BDNF-TrkB signaling under chronic treatment with 5-HT2A agonists.
Keywords: 25CN-NBOH; 5-HT2A receptors; BDNF system; DOI; TCB-2; behavior.
Similar articles
- Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB.Halberstadt AL, et al.Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17.Psychopharmacology (Berl). 2019.PMID:30448990Free PMC article.
- Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB.Amodeo DA, et al.Behav Brain Res. 2020 Oct 1;395:112861. doi: 10.1016/j.bbr.2020.112861. Epub 2020 Aug 16.Behav Brain Res. 2020.PMID:32814148
- Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties ofN-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist.Jensen AA, McCorvy JD, Leth-Petersen S, Bundgaard C, Liebscher G, Kenakin TP, Bräuner-Osborne H, Kehler J, Kristensen JL.Jensen AA, et al.J Pharmacol Exp Ther. 2017 Jun;361(3):441-453. doi: 10.1124/jpet.117.239905. Epub 2017 Mar 30.J Pharmacol Exp Ther. 2017.PMID:28360333
- 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.Märcher Rørsted E, Jensen AA, Kristensen JL.Märcher Rørsted E, et al.ChemMedChem. 2021 Nov 5;16(21):3263-3270. doi: 10.1002/cmdc.202100395. Epub 2021 Aug 21.ChemMedChem. 2021.PMID:34288515Review.
- TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?Di Giovanni G, De Deurwaerdère P.Di Giovanni G, et al.Neuropharmacology. 2018 Nov;142:20-29. doi: 10.1016/j.neuropharm.2017.10.004. Epub 2017 Oct 4.Neuropharmacology. 2018.PMID:28987938Review.
Cited by
- 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.Glennon RA, Dukat M.Glennon RA, et al.ACS Pharmacol Transl Sci. 2024 May 8;7(6):1722-1745. doi: 10.1021/acsptsci.4c00157. eCollection 2024 Jun 14.ACS Pharmacol Transl Sci. 2024.PMID:38898956Review.
- TrkB receptor interacts with mGlu2 receptor and mediates antipsychotic-like effects of mGlu2 receptor activation in the mouse.Philibert CE, Disdier C, Lafon PA, Bouyssou A, Oosterlaken M, Galant S, Pizzoccaro A, Tuduri P, Ster J, Liu J, Kniazeff J, Pin JP, Rondard P, Marin P, Vandermoere F.Philibert CE, et al.Sci Adv. 2024 Jan 26;10(4):eadg1679. doi: 10.1126/sciadv.adg1679. Epub 2024 Jan 26.Sci Adv. 2024.PMID:38277461Free PMC article.
- Impact of specific serotonin receptor modulation on restricted repetitive behaviors.Alvarez BD, Cavazos C, Morales CA, M Lopez S, Amodeo DA.Alvarez BD, et al.Front Behav Neurosci. 2022 Dec 23;16:1078983. doi: 10.3389/fnbeh.2022.1078983. eCollection 2022.Front Behav Neurosci. 2022.PMID:36620862Free PMC article.Review.
- Psychedelic-inspired approaches for treating neurodegenerative disorders.Saeger HN, Olson DE.Saeger HN, et al.J Neurochem. 2022 Jul;162(1):109-127. doi: 10.1111/jnc.15544. Epub 2021 Dec 5.J Neurochem. 2022.PMID:34816433Free PMC article.Review.
- Preferential Modulatory Action of 5-HT2A Receptors on the Dynamic Regulation of Basal Ganglia Circuits.Guilhemsang L, Gutierrez-Ceballos A, Antonazzo M, Mallet NP, Ugedo L, Morera-Herreras T.Guilhemsang L, et al.J Neurosci. 2023 Jan 4;43(1):56-67. doi: 10.1523/JNEUROSCI.1181-22.2022. Epub 2022 Nov 18.J Neurosci. 2023.PMID:36400530Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Research Materials